Combatting cardiovascular disease today
Cardiovascular disease remains the most common cause of death in the UK and across the world, so in this issue of BioScience Today, Ellen Rossiter speaks to Dr Vijay Kunadian, Senior Lecturer and Honorary...
Six Years of Exercise or Lack of It – May Be Enough to Change...
By analyzing reported physical activity levels over time in more than 11,000 American adults, Johns Hopkins Medicine researchers conclude that increasing physical activity to recommended levels over as few as six years in middle...
Ulster University leads on €8.2M cross border collaborative research centre
The EU funded cross border centre of research excellence in cardiovascular medicine will transform cardiac care in the region by developing new models of care, smart wearable technologies and improved patient monitoring systems.
The Eastern...
Breaking through cardiovascular disease
Professor Metin Avkiran, Associate Medical Director at the British Heart Foundation (BHF) explains the work they are doing to find the next breakthrough treatment for cardiovascular disease.
Since the BHF was formed over 50 years...
The Great British Biosimilar Journey
Attitudes towards biosimilar drugs have rapidly changed in the last 24 months, but there is still work to do. Divya Chadha Manek from the National Institute for Health Research (NIHR) – the research arm...
What is Life?
In 1943, the quantum physicist Erwin Schrödinger stood up in Trinity College Dublin and delivered what might be described as the biggest scientific disappointment of the century. His work on quantum mechanics, which so...
Unlocking the secrets of a killer
Scientists are making significant progress to improve the testing and treatment of the killer illness salmonella.
Achieving success is vital because every year almost one in ten people fall ill to food-borne illnesses, with many...
Campus is well placed as Northern bioeconomy prepares for strong growth
The bioeconomy in the North of England stands on the cusp of signifigant expansion and one of the science parks which is ready to play its part is the National Agri-Food Innovation Campus (NAFIC).
Situated...
The battle against polio – still work to be done
People of a certain age in the Western World will have haunting recollections of a disease that laid waste to vast numbers of young people. A cruel disease that filled sanitoriums with rows of...
Research offers hope
There is hope in the battle against drug-resistant drugs, though. For example, a newly discovered antibiotic, produced by bacteria from a cystic fibrosis patient, could be used to treat cases of drug-resistant tuberculosis (TB),...
Why we need to tackle resistant diseases
Crisis can be an over-used word but in the case of antimicrobial resistance it is entirely apt.
According to health organisations the world over, the need to come up with new solutions to illnesses that...
Impact of latest innovative gastroenterology research for patient benefit
According to the British Society of Gastroenterology, the burden of gastrointestinal and liver disease is heavy for patients, the NHS, and the economy. Gastrointestinal disease is the third most common cause of death, and...
Research deepens understanding of malaria parasite
Science carried out in Nottingham helped to form the foundation for the latest breakthrough in the global fight against malaria.
Researchers in the University of Nottingham’s School of Life Sciences were responsible for the identification...
Fighting the battle against malaria
Despite major breakthroughs in medicine over the years, some diseases remain mass killers and few cast a longer shadow than malaria, particularly in Africa where it has claimed millions of lives.
Key to tackling the...
Nemera receives Drug Manufacturing Authorization for its Neuenburg plant, in Germany
Important achievement for Nemera, now able to handle, assemble, sterilize and store pharmaceutical drugs and medicinal products for autoinjectors.
On 4th September, Nemera received from the German Government Drug Administration (Government Presidium, Tübingen) the...
Changes in drug delivery open up commercial opportunities
After centuries of delivering drugs to patients as pills, liquids and injectables a revolution is under way which will change everything for patients - from the dose needed to the frequency of administration.
Life for...